○ASCOレポート
1.Retrospective analysis of CA19-9 decrease in patients
with metastatic pancreatic carcinoma(MPC) treated with
FOLFIRINOX or gemcitabine(gem) in a randomized
phase III study(ACCORD11/PRODIGE4).
2.Randomized phase ? study of gemcitabine plus S-1
combination therapy versus gemcitabine plus cisplatin
combination therapy in advanced biliary tract cancer:
A Japan Clinical Oncology Group study(JCOG1113).